Cargando…

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years

Hepatitis C virus (HCV) is a global health concern associated with significant morbidity and mortality. Before the approval of second-generation direct-acting antiviral agents (DAAs), interferon therapy and liver transplantation constituted the mainstay of treatment. The introduction of well-tolerat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dennis, Brittany B, Naji, Leen, Jajarmi, Yasmin, Ahmed, Aijaz, Kim, Donghee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371499/ https://www.ncbi.nlm.nih.gov/pubmed/34447228 http://dx.doi.org/10.3748/wjg.v27.i29.4818

Ejemplares similares

Update on global epidemiology of viral hepatitis and preventive strategies
por: Jefferies, Meryem, et al.
Publicado: (2018)

Viral hepatitis: Innovations and expectations
por: Leoni, Simona, et al.
Publicado: (2022)

Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
por: Sagnelli, Caterina, et al.
Publicado: (2022)

Personalized medicine in multiple sclerosis: hope or reality?
por: Derfuss, Tobias
Publicado: (2012)

Pancreatic cancer: New hopes after first line treatment
por: Aroldi, Francesca, et al.
Publicado: (2016)

HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
por: Barnes, Tristan A, et al.
Publicado: (2017)

Stem cells from adipose tissue and breast cancer: hype, risks and hope
por: Bertolini, F, et al.
Publicado: (2015)

Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
por: Gkolfinopoulos, Stavros, et al.
Publicado: (2017)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Epidemiology of hepatitis E in South-East Europe in the "One Health" concept
por: Mrzljak, Anna, et al.
Publicado: (2019)

COVID-19 and comorbidities of hepatic diseases in a global perspective
por: Ahmad, Aqsa, et al.
Publicado: (2021)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

Innovations in oligonucleotide drug delivery
por: Lysik, Melanie A., et al.
Publicado: (2003)

Tasting the terroir of wine yeast innovation
por: Pretorius, I S
Publicado: (2019)

Trends and Innovations in Biosensors for COVID‐19 Mass Testing
por: Santiago, Ibon
Publicado: (2020)

Radiation protection for the interventional cardiologist: Practical approach and innovations
por: Gutierrez-Barrios, Alejandro, et al.
Publicado: (2022)

Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
por: da Costa, Adriano Carneiro, et al.
Publicado: (2020)

Neurodevelopmental disorders: An innovative perspective via the response to intervention model
por: Rodríguez, Celestino, et al.
Publicado: (2021)

Exploiting epidemiological data to understand the epidemiology and factors that influence COVID-19 pandemic in Libya
por: Mahmoud, Abdusalam S, et al.
Publicado: (2021)

Management of acute spinal cord injury: A summary of the evidence pertaining to the acute management, operative and non-operative management
por: Sandean, Darren
Publicado: (2020)

Recent and emerging innovations in Salmonella detection: a food and environmental perspective
por: Bell, Rebecca L., et al.
Publicado: (2016)

Role of innovative 3D printing models in the management of hepatobiliary malignancies
por: Bangeas, Peter, et al.
Publicado: (2019)

Modern yeast development: finding the balance between tradition and innovation in contemporary winemaking
por: Gardner, Jennifer M, et al.
Publicado: (2022)

Epidemiologic studies of the human microbiome and cancer
por: Vogtmann, Emily, et al.
Publicado: (2016)

Diabetes and cancer: Epidemiological and biological links
por: Wang, Mina, et al.
Publicado: (2020)

Innovative training networks: overview of the Marie Skłodowska-Curie PhD training model
por: Doonan, Francesca, et al.
Publicado: (2018)

Innovation of endoscopic management in difficult common bile duct stone in the era of laparoscopic surgery
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2021)

Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention
por: Oneda, Ester, et al.
Publicado: (2021)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Epidemiology of soy exposures and breast cancer risk
por: Wu, A H, et al.
Publicado: (2008)

Epidemiology of sickle cell disease in Saudi Arabia
por: Jastaniah, Wasil
Publicado: (2011)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis
por: Harputluoglu, Murat, et al.
Publicado: (2022)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021)

Epidemiology, determinants, and management of AIDS cholangiopathy: A review
por: Naseer, Maliha, et al.
Publicado: (2018)

Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
por: Rehman, Syed Tabish, et al.
Publicado: (2021)

Inequity in the global distribution of monkeypox vaccines
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2023)

Hepatic senescence, the good and the bad
por: Huda, Nazmul, et al.
Publicado: (2019)

Artificial intelligence for hepatitis evaluation
por: Liu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bakdpohkj90qcuhaibvtg0reno